These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 1620268
1. 4-Bromoacetamidoprocaine: an affinity ligand for brain muscarinic and nicotinic cholinergic receptors. Saraswati M, Hashmi M, Abood LG. Neurochem Res; 1992 Mar; 17(3):247-52. PubMed ID: 1620268 [Abstract] [Full Text] [Related]
2. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors. Abood LG, Saraswati M, Lerner-Marmarosh N, Hashmi M. Biochem Pharmacol; 1993 May 25; 45(10):2143-8. PubMed ID: 8512596 [Abstract] [Full Text] [Related]
3. Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain. Anderson DJ, Arneric SP. Eur J Pharmacol; 1994 Mar 03; 253(3):261-7. PubMed ID: 8200419 [Abstract] [Full Text] [Related]
4. Differences in ligand binding and phosphoinositide turnover between M1 muscarinic receptor gene transfected cells and mouse and rat brain membranes. Wang DX, Lerner-Marmarosh N, Sheu SS, Sharma V, Jou MJ, Abood LG. Pharmacol Biochem Behav; 1994 Oct 03; 49(2):405-11. PubMed ID: 7824557 [Abstract] [Full Text] [Related]
5. [3H]methylcarbamylcholine, a new radioligand for studying brain nicotinic receptors. Abood LG, Grassi S. Biochem Pharmacol; 1986 Dec 01; 35(23):4199-202. PubMed ID: 3790148 [Abstract] [Full Text] [Related]
6. Analogues of carbacholine: synthesis and relationship between structure and affinity for muscarinic and nicotinic acetylcholine receptors. Søkilde B, Mikkelsen I, Stensbøl TB, Andersen B, Ebdrup S, Krogsgaard-Larsen P, Falch E. Arch Pharm (Weinheim); 1996 Feb 01; 329(2):95-104. PubMed ID: 8851473 [Abstract] [Full Text] [Related]
7. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain. Luthin GR, Wolfe BB. J Pharmacol Exp Ther; 1985 Jul 01; 234(1):37-44. PubMed ID: 3839265 [Abstract] [Full Text] [Related]
8. Alterations in muscarinic cholinergic receptors after preganglionic denervation of the superior cervical ganglion in cats. Taniguchi T, Kurahashi K, Fujiwara M. J Pharmacol Exp Ther; 1983 Mar 01; 224(3):674-8. PubMed ID: 6827488 [Abstract] [Full Text] [Related]
9. 5-Isothiocyanonicotine: a high-affinity irreversible ligand for brain nicotinic receptors. Kim KD, Lerner-Marmarosh N, Saraswati M, Kende AS, Abood LG. Biochem Pharmacol; 1994 Jun 01; 47(11):1965-7. PubMed ID: 8010981 [Abstract] [Full Text] [Related]
10. Muscarinic cholinergic receptors in human foetal brain: characterization and ontogeny of [3H]quinuclidinyl benzilate binding sites in frontal cortex. Ravikumar BV, Sastry PS. J Neurochem; 1985 Jan 01; 44(1):240-6. PubMed ID: 3964831 [Abstract] [Full Text] [Related]
11. Studies of muscarinic and nicotinic binding sites in brain. Nordberg A, Larsson C. Acta Physiol Scand Suppl; 1980 Jan 01; 479():19-23. PubMed ID: 6932800 [Abstract] [Full Text] [Related]
12. Evidence for muscarinic cholinergic receptors in dog portal vein: binding of [3H]quinuclidinyl benzilate. Taniguchi T, Tsukahara T, Fujiwara M. Life Sci; 1983 Apr 11; 32(15):1757-63. PubMed ID: 6835022 [Abstract] [Full Text] [Related]
13. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. Shimohama S, Taniguchi T, Fujiwara M, Kameyama M. J Neurochem; 1986 Jan 11; 46(1):288-93. PubMed ID: 3940287 [Abstract] [Full Text] [Related]
14. Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover. Akiyama K, Vickroy TW, Watson M, Roeske WR, Reisine TD, Smith TL, Yamamura HI. J Pharmacol Exp Ther; 1986 Mar 11; 236(3):653-61. PubMed ID: 3005550 [Abstract] [Full Text] [Related]
15. In vitro evidence and age-related changes for nicotinic but not muscarinic acetylcholine receptors in the central nervous system of Sepia officinalis. Bellanger C, Halm MP, Dauphin F, Chichery R. Neurosci Lett; 2005 Oct 28; 387(3):162-7. PubMed ID: 16026931 [Abstract] [Full Text] [Related]
16. Differential distribution of muscarinic cholinergic and putative nicotinic cholinergic receptors within the hypothalamo-neurohypophysial system of the rat. Michels KM, Meeker RB, Hayward JN. Neuroendocrinology; 1986 Oct 28; 44(4):498-507. PubMed ID: 3822079 [Abstract] [Full Text] [Related]
17. Inhibition by local anesthetics, phentolamine and propranolol of [3H]quinuclydinyl benzylate binding to central muscarinic receptors. Aguilar JS, Criado M, De Robertis E. Eur J Pharmacol; 1980 Dec 05; 68(3):317-26. PubMed ID: 7202495 [Abstract] [Full Text] [Related]
18. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors. Baker SP, Posner P. Mol Pharmacol; 1986 Nov 05; 30(5):411-8. PubMed ID: 3773882 [Abstract] [Full Text] [Related]
19. Interaction of 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride, ryanodine and procaine with muscarinic cholinergic M2 receptor sites in smooth muscle. Hisayama T, Takayanagi I, Kumagai N, Kubo H. J Pharmacol Exp Ther; 1989 May 05; 249(2):646-51. PubMed ID: 2724145 [Abstract] [Full Text] [Related]
20. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium. Dunlap J, Brown JH. Mol Pharmacol; 1983 Jul 05; 24(1):15-22. PubMed ID: 6135150 [Abstract] [Full Text] [Related] Page: [Next] [New Search]